ANG-900 series

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameANG-900 series
Drug Alias Namevascular-targeted gene therapies (Angiogene Pharmaceuticals)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngiogene Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngiogene Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A